Paper9832620
Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen.
Miyazawa K and 2 others. J Biochem, 1998. Cited by 113 papers, by iCite.
Cite this record
ConductScience Library. Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen. Papers, record 9832620. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9832620
- Cell line
- MH7A6 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Polyomavirus Transforming | Major topic |
| Arthritis, Rheumatoid | Major topic |
| Cell Line, Transformed | Major topic |
| Mitogen-Activated Protein Kinases | Major topic |
| Synovial Membrane | Major topic |
| Antigens, Surface | |
| Calcium-Calmodulin-Dependent Protein Kinases | |
| Dexamethasone | |
| Fibroblasts | |
| Flavonoids | |
| Growth Substances | |
| Humans | |
| Imidazoles | |
| Interleukin-1 | |
| Interleukin-6 | |
| Intracellular Signaling Peptides and Proteins | |
| Matrix Metalloproteinase 3 | |
| Mitogen-Activated Protein Kinase 1 | |
| Protein Serine-Threonine Kinases | |
| Pyridines | |
| Receptors, Interleukin-1 | |
| Transfection | |
| p38 Mitogen-Activated Protein Kinases | |
| MAP-Kinase-Activated Kinase 2 |
Source PubMed
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943348 | A Pathway-Driven Computational Drug Discovery Framework Integrating Machine Learning and Virtual Screening for Identification of Anti-Rheumatoid Arthritis Natural Small Molecules. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943348 | PubMed |
| 42662346 | Extraction, Purification of C‑Glycosides from Arisaema decipiens for Studying its Anti-Inflammatory and Bioactivities. | ACS Omega | 2026 | https://conductscience.org/library/papers/42662346 | PubMed |
| 42198459 | Liquiritigenin Ameliorates Rheumatoid Arthritis by Modulating the Nrf2/NF-κB/NLRP3 Pathway in Fibroblast-like Synoviocytes. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198459 | PubMed |
| 41634281 | Two new mycobactins, mycobactins U and V, and their ferric complexes isolated from Mycolicibacterium septicum IFM 12283. | J Nat Med | 2026 | https://conductscience.org/library/papers/41634281 | PubMed |
| 40959556 | miR-548aj-3p and miR-3127-3p suppress RANKL-facilitated inflammatory cytokines and catabolic factor in osteoarthritis and rheumatoid arthritis. | Int J Med Sci | 2025 | https://conductscience.org/library/papers/40959556 | PubMed |
| 39367607 | Bone-protective effects of neutralizing angiopoietin-like protein 4 monoclonal antibody in rheumatoid arthritis. | Mol Ther | 2024 | https://conductscience.org/library/papers/39367607 | PubMed |
| 39122458 | Redefinition of Synovial Fibroblasts in Rheumatoid Arthritis. | Aging Dis | 2024 | https://conductscience.org/library/papers/39122458 | PubMed |
| 38592349 | New biflavonoids isolated from Xylia kerrii leaves extract with selective cytotoxicity against MH7A human rheumatoid arthritis synovial fibroblast cells. | J Nat Med | 2024 | https://conductscience.org/library/papers/38592349 | PubMed |
| 37480451 | Novel HIF-1α Inhibitor AMSP-30m Mitigates the Pathogenic Cellular Behaviors of Hypoxia-Stimulated Fibroblast-Like Synoviocytes and Alleviates Collagen-Induced Arthritis in Rats via Inhibiting Sonic Hedgehog Pathway. | Inflammation | 2023 | https://conductscience.org/library/papers/37480451 | PubMed |
| 36969583 | Simultaneous quantitative analysis and in vitro anti-arthritic effects of five polyphenols from Terminalia chebula. | Front Physiol | 2023 | https://conductscience.org/library/papers/36969583 | PubMed |
| 36941600 | Circ_0000479 promotes proliferation, invasion, migration and inflammation and inhibits apoptosis of rheumatoid arthritis fibroblast-like synoviocytes via miR-766/FKBP5 axis. | J Orthop Surg Res | 2023 | https://conductscience.org/library/papers/36941600 | PubMed |
| 36675245 | DHA Induces Cell Death through the Production of ROS and the Upregulation of CHOP in Fibroblast-like Synovial Cells from Human Rheumatoid Arthritis Patients. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36675245 | PubMed |
| 35804814 | Generation of the Chondroprotective Proteomes by Activating PI3K and TNFα Signaling. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35804814 | PubMed |
| 35611061 | Specialized Pro-Resolving Mediators Do Not Inhibit the Synthesis of Inflammatory Mediators Induced by Tumor Necrosis Factor-α in Synovial Fibroblasts. | Yonago Acta Med | 2022 | https://conductscience.org/library/papers/35611061 | PubMed |
| 35236422 | Anti-inflammatory effects of Jingshu Keli capsule and its components on human synoviocyte MH7A cells. | Arthroplasty | 2020 | https://conductscience.org/library/papers/35236422 | PubMed |
| 34975889 | Antcin K Inhibits TNF-α, IL-1β and IL-8 Expression in Synovial Fibroblasts and Ameliorates Cartilage Degradation: Implications for the Treatment of Rheumatoid Arthritis. | Front Immunol | 2021 | https://conductscience.org/library/papers/34975889 | PubMed |
| 34281218 | B Cell Adhesion to Fibroblast-Like Synoviocytes Is Up-Regulated by Tumor Necrosis Factor-Alpha via Expression of Human Vascular Cell Adhesion Molecule-1 Mediated by B Cell-Activating Factor. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34281218 | PubMed |
| 33542641 | Inducing Apoptosis and Suppressing Inflammatory Reactions in Synovial Fibroblasts are Two Important Ways for Guizhi-Shaoyao-Zhimu Decoction Against Rheumatoid Arthritis. | J Inflamm Res | 2021 | https://conductscience.org/library/papers/33542641 | PubMed |
| 33415454 | Modulation of TNFR 1-triggered two opposing signals for inflammation and apoptosis via RIPK 1 disruption by geldanamycin in rheumatoid arthritis. | Clin Rheumatol | 2021 | https://conductscience.org/library/papers/33415454 | PubMed |
| 32817908 | Peripheral mechanisms of arthritic pain: A proposal to leverage large animals for in vitro studies. | Neurobiol Pain | 2020 | https://conductscience.org/library/papers/32817908 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9832620
GET https://conductscience.org/api/papers/v1/9832620/cited_by?page=2